688189 南新製藥
按盤價 
7.230 +0.840 (+13.146%) | 2024/06 - 中期 人民幣(K¥) | 與去年末期 比較 | 2023/12 人民幣(K¥) | 2022/12 人民幣(K¥) | 2021/12 人民幣(K¥) | 2020/12 人民幣(K¥) | |
非流動資產 | ||||||
| 長期股權投資 | 0 | -- | 0 | 0 | 0 | 0 |
| 投資性房地產 | 0 | -- | 0 | 0 | 0 | 0 |
| 固定資產 | 176,584 | -4.49% | 184,895 | 200,731 | 223,585 | 226,720 |
| 在建工程 | 593 | 3.49% | 573 | 240 | 1,275 | 516 |
| 無形資產 | 136,839 | 10.10% | 124,284 | 138,006 | 158,413 | 65,569 |
| 商譽 | 10,845 | 0.00% | 10,845 | 10,845 | 13,569 | 28,256 |
| 其他非流動資產 | 123,665 | -2.57% | 126,928 | 108,614 | 120,846 | 51,814 |
| 448,526 | 0.22% | 447,525 | 458,436 | 517,689 | 372,875 | |
流動資產 | ||||||
| 貨幣資金 | 529,023 | -20.54% | 665,761 | 713,472 | 730,668 | 299,351 |
| 應收賬款 | 503,751 | -7.39% | 543,962 | 728,193 | 590,813 | 639,973 |
| 存貨 | 41,385 | 45.64% | 28,416 | 27,015 | 61,425 | 53,337 |
| 其他流動資產 | 20,271 | -60.92% | 51,872 | 27,492 | 230,275 | 720,483 |
| 1,094,430 | -15.16% | 1,290,011 | 1,496,172 | 1,613,181 | 1,713,144 | |
流動負債 | ||||||
| 短期借款 | 155,121 | -51.97% | 322,950 | 488,733 | 385,437 | 235,249 |
| 應付票據 | 0 | -- | 0 | 0 | 80,000 | 0 |
| 應付帳款 | 33,193 | -16.07% | 39,548 | 37,496 | 76,467 | 20,208 |
| 其他流動負債 | 60,646 | -9.41% | 66,944 | 122,127 | 132,766 | 126,141 |
| 248,959 | -42.03% | 429,442 | 648,355 | 674,671 | 381,598 | |
| 流動資產淨值 | 845,470 | -1.75% | 860,569 | 847,817 | 938,510 | 1,331,546 |
| 資產總額減流動負債 | 1,293,996 | -1.08% | 1,308,095 | 1,306,253 | 1,456,199 | 1,704,421 |
非流動負債 | ||||||
| 長期借款 | 0 | -- | 0 | 0 | 50,846 | 76,260 |
| 應付債券 | 0 | -- | 0 | 0 | 0 | 0 |
| 其他非流動負債 | 5,301 | -8.10% | 5,768 | 9,881 | 11,370 | 9,010 |
| 5,301 | -8.10% | 5,768 | 9,881 | 62,216 | 85,270 | |
總權益 | ||||||
| 實收股本 | 274,400 | 0.00% | 274,400 | 196,000 | 140,000 | 140,000 |
| 儲備項目 | 1,031,271 | -1.19% | 1,043,716 | 1,118,365 | 1,253,197 | 1,455,818 |
| 股東權益 | 1,305,671 | -0.94% | 1,318,116 | 1,314,365 | 1,393,197 | 1,595,818 |
| 非控股權益 | (16,977) | 7.52% | (15,790) | (17,993) | 786 | 23,333 |
| 備註： | 即時報價更新時間為 30/09/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
